61 studies found for:    Paraneoplastic Syndromes
Show Display Options
Rank Status Study
21 Completed Effectiveness of Rituximab in Pediatric OMS Patients.
Conditions: Opsoclonus-myoclonus Syndrome;   Opsoclonus;   Myoclonus;   Ataxia
Intervention: Drug: rituximab
22 Unknown  MC-5A for Chemotherapy Induced Peripheral Neuropathy
Condition: Neuropathy, Paraneoplastic
Interventions: Device: MC-5A;   Drug: Sham device
23 Recruiting National Registry for Egyptian Pediatric Neuromuscular Diseases
Conditions: Spinal Muscular Atrophy;   Muscular Dystrophy;   Muscle Diseases;   Myasthenic Syndromes;   Polyneuropathies
Intervention:
24 Unknown  Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone
Conditions: Acute Disseminated Encephalomyelitis;   Devic's Syndrome;   Marburg's Variant of Multiple Sclerosis;   Balo's Concentric Sclerosis;   Acute Transverse Myelitis
Intervention: Procedure: Plasma exchange
25 Enrolling by invitation Controlled Trial of 3,4-Diaminopyridine (3-4DAP) in Lambert-Eaton Myasthenic Syndrome (LEMS)
Condition: Muscle Weakness
Intervention: Drug: 3-4 Diaminopyridine
26 Completed Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis
Conditions: Multiple Sclerosis;   Optic Neuritis;   Transverse Myelitis;   Acute Brainstem/Cerebellar Syndrome
Intervention: Drug: interferon beta 1a 30 ug IM once weekly
27 Enrolling by invitation Ephedrine for the Treatment of Congenital Myasthenia
Condition: Myasthenic Syndromes, Congenital
Intervention: Drug: Ephedrine
28 Enrolling by invitation Biobank For MS And Other Demyelinating Diseases
Conditions: Multiple Sclerosis;   Transverse Myelitis;   Neuromyelitis Optica;   Acute Disseminated Encephalomyelitis;   Optic Neuritis
Intervention:
29 Completed One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study
Conditions: Osteoporosis;   Humoral Hypercalcemia of Malignancy;   Hyperparathyroidism
Intervention: Drug: Parathyroid Hormone-related Protein (1-36)
30 Not yet recruiting One Week Comparison Study of PTH and PTHrP Infusions
Conditions: Osteoporosis;   Hypercalcemia of Malignancy;   Hyperparathyroidism;   Bone Diseases, Endocrine
Interventions: Drug: Parathyroid Hormone-related Protein (1-36);   Drug: parathyroid hormone (1-34);   Drug: PTH (1-34) and PTHrP (1-36)
31 Active, not recruiting Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer
Conditions: Breast Cancer;   Hypercalcemia of Malignancy;   Metastatic Cancer
Interventions: Drug: ibandronate sodium;   Drug: zoledronic acid;   Drug: Zolendronic Acid
32 Completed Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Conditions: Breast Cancer;   Hypercalcemia of Malignancy;   Colon Cancer;   Endocrine Cancer;   Head and Neck Cancer;   Kidney Cancer;   Lung Cancer;   Lymphoma;   Metastatic Cancer;   Multiple Myeloma;   Parathyroid Neoplasms;   Renal Cancer;   Thyroid Cancer;   Hodgkin's Lymphoma;   Non-Hodgkin's Lymphoma;   Non-Small Cell Lung Cancer
Intervention: Drug: denosumab
33 Unknown  Comparison of Two Schedules of Zoledronic Acid in Treating Patients With Breast Cancer That Has Spread to the Bone
Conditions: Breast Cancer;   Hypercalcemia of Malignancy;   Metastatic Cancer;   Musculoskeletal Complications;   Pain
Interventions: Drug: zoledronic acid;   Procedure: quality-of-life assessment
34 Withdrawn S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone
Conditions: Breast Cancer;   Hypercalcemia of Malignancy;   Metastatic Cancer;   Pain
Interventions: Drug: ibandronate;   Drug: zoledronate;   Procedure: quality-of-life assessment
35 Completed Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases
Conditions: Breast Cancer;   Hypercalcemia of Malignancy;   Metastatic Cancer;   Pain
Interventions: Biological: monoclonal antibody CAL;   Drug: zoledronic acid
36 Completed Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone
Conditions: Hypercalcemia of Malignancy;   Lung Cancer;   Metastatic Cancer;   Pain;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: zoledronic acid;   Procedure: quality-of-life assessment
37 Unknown  Use of Rituximab in Opsoclonus-Myoclonus in Children With Neuroblastoma
Conditions: Neuroblastoma;   Opsoclonus-Myoclonus
Intervention: Drug: anti-CD20 (Rituximab)
38 Recruiting Safety and Efficacy of Sustained Release Dalfampridine in Transverse Myelitis (Re-Launch)
Conditions: Transverse Myelitis;   Neuromyelitis Optica;   Idiopathic Transverse Myelitis;   Myelitis NOS
Interventions: Drug: Dalfampridine;   Drug: Placebo
39 Recruiting Transcranial Direct Current Stimulation on Cortical Plasticity in Patients With Anti-NMDA Receptor Encephalitis
Condition: Anti-NMDA Receptor Encephalitis
Interventions: Device: tDCS;   Device: Sham Stimulation
40 Recruiting A Longitudinal Study of Neuromyelitis Optica and Transverse Myelitis
Conditions: Neuromyelitis Optica;   Neuromyelitis Optica Spectrum Disorder;   Transverse Myelitis;   Optic Neuritis
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years